Paper

Metabolic remodelling in hiPSC-derived myofibres carrying the m.3243A>G mutation

Pitceathly, Robert D. S., Tedesco, Francesco Saverio, Valdebenito, Gabriel E., Chi, Haoyu, Sheshadri, Preethi, Duchen, Michael R., Chacko, Anitta R., Houlden, Henry, Chung, Chih-Yao, Rouse, Hannah, O’Callaghan, Benjamin, Bianchi, Katiuscia, Morales, Valle

2024

Overview

Mutations in mitochondrial DNA cause severe multisystem disease, frequently associated with muscle weakness. The m.3243A>G mutation is the major cause of Mitochondrial Encephalomyopathy Lactic Acidosis and Stroke Like episodes (MELAS). Experimental models that recapitulate the disease phenotype in vitro for disease modelling or drug screening are very limited. We have therefore generated hiPSC-derived muscle fibres with variable heteroplasmic mtDNA mutation load without significantly affecting muscle differentiation potential. The cells are excitable and show physiological characteristics of muscle fibres and show well organised myofibrillar structure. In cells carrying the m.3243A>G, the mitochondrial membrane potential and oxygen consumption were reduced in relation to the mutant load. We have shown through proteomic, phosphoproteomic, and metabolomic analyses that the m.3243A>G mutation variably affects the cell phenotype in relation to the mutant load. This variation is reflected by an increase in the NADH/NAD+ ratio, which in turns influences key nutrient-sensing pathways in the myofibres. This model enables detailed study of the impact of the mutation on cellular bioenergetics and on muscle physiology with the potential to provide a platform for drug screening.

• Publisher: Cold Spring Harbor Laboratory
• Subject: Cell Biology